<DOC>
	<DOCNO>NCT02852018</DOCNO>
	<brief_summary>The aim project identify common genetic polymorphism associate occurrence rhythmic event patient severe cardiomyopathy .</brief_summary>
	<brief_title>Identification Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Patients implant primary prevention , implantable cardioverter defibrillator ( ICD ) single double room , severe cardiomyopathy ( EF &lt; 35 % ) Patients ischemic cardiomyopathy idiopathic dilate cardiomyopathy . `` Appropriate treatment '' group : patient rhythmic event ( inclusion ) appropriately treat either administer electric shock antiarrhythmic stimulation Group `` event '' patient never receive treatment electrical antiarrhythmic stimulation minimum followup three year inclusion receive proper treatment follow period study Patients implant ICD primary prevention context family hereditary disease ( long QT syndrome , Brugada syndrome , hypertrophic cardiomyopathy , ventricular tachycardia catecholergic right ventricular dysplasia ... ) . Patients leave ventricular function great 35 % . Patients implanted defibrillator function resynchronization . Patients minor , adult guardianship protected person eligible project .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>